The lenses measure glucose levels of tears and push this data to a user’s smartphone
When it comes to technology, we cannot even for a second doubt the innovative abilities of the search giant Google and now its presence in the mobile industry is truly mesmerizing. The Google Glass for instance, though controversial, is the most popular device but that isn’t the only project which the company is working on. The smart contact lenses seem to be in the pipeline. These lenses are going to offer significant health benefits those suffering with diabetes and this project soared to a new height as Google went into a licensing deal with Novartis subsidiary Alcon. Though we are thinking there wont be anyone who wont be familiar with Novartis, but just for the benefit of the few of those who don’t, it is a pharmaceutical giant and the most well known in the industry and Alcon serves as its eye care division.
Don't Miss: The Best CES 2017 Gadgets
This deal between two giant companies is a huge deal particularly for Google and its smart lenses project. These lenses with the ability to measure glucose levels of tears and push this data to a user’s smartphone, and with the ability to alert a diabetic when these levels are too high, it is the most health centered product. The smart lenses have run through a couple of trials but this deal with Novartis is just the confirmation we needed.